Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

Ryan Phillips; William Y. Shi; Matthew P. Deek; Noura Radwan; Su Jin Lim; Emmanuel S. Antonarakis; Steven P. Rowe; Ashley E. Ross; Michael A. Gorin; Curtiland Deville; Stephen Greco; Hailun Wang; Samuel R. Denmeade; Channing J. Paller; Shirl Dipasquale; Theodore L. DeWeese; Daniel Y. Song; Hao Wang; Michael A. Carducci; Kenneth J. Pienta; Martin G. Pomper; Adam P. Dicker; Mario A. Eisenberger; Ash A. Alizadeh; Maximilian Diehn; Phuoc T. Tran

doi:10.1001/jamaoncol.2020.0147

Abstract

ClinicalTrials.gov Identifier: NCT02680587.

Keywords

SABR volatility modelMedicineProstate cancerRandomized controlled trialAndrogen deprivation therapyProstateRadiation therapyProstate-specific antigenOncologyInternal medicineRadiosurgeryCancerSurgery

Affiliated Institutions

Related Publications

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma , Robert Olson , Stephen Harrow +21 more

PURPOSE The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease ...

2020 Journal of Clinical Oncology 1129 citations

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma , Robert Olson , Stephen Harrow +19 more

The oligometastatic paradigm suggests that some patients with a limited number of metastases might be cured if all lesions are eradicated. Evidence from randomised controlled tr...

2019 The Lancet 1754 citations

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

David A. Reardon , Alba A. Brandes , Antonio Omuro +17 more

ClinicalTrials.gov Identifier: NCT02017717.

2020 JAMA Oncology 1314 citations

Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials

Early Breast Cancer Trialists' Collaborative Group

<p><strong>Background</strong>\nRandomized trials of radiotherapy and surgery for early breast cancer may have been too small to detect differences in long-ter...

1996 New England Journal of Medicine 785 citations

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Freddie C. Hamdy , Jenny Donovan , J. Athene Lane +27 more

After 15 years of follow-up, prostate cancer-specific mortality was low regardless of the treatment assigned. Thus, the choice of therapy involves weighing trade-offs between be...

2023 New England Journal of Medicine 605 citations

Publication Info

Year: 2020
Type: article
Volume: 6
Issue: 5
Pages: 650-650
Citations: 1037
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1037

OpenAlex

Cite This

APA Style

                            
                                
                                    Ryan Phillips, 
                                
                                    William Y. Shi, 
                                
                                    Matthew P. Deek
                                
                                et al.
                            
                            (2020). 
                            Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer. 
                            JAMA Oncology
                            , 6
                            (5)
                            , 650-650.
                            https://doi.org/10.1001/jamaoncol.2020.0147
                        

Identifiers

DOI: 10.1001/jamaoncol.2020.0147